These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33084455)

  • 21. Association between preoperative aspirin and acute kidney injury following coronary artery bypass grafting.
    Aboul-Hassan SS; Marczak J; Stankowski T; Peksa M; Nawotka M; Stanislawski R; Cichon R
    J Thorac Cardiovasc Surg; 2020 Sep; 160(3):712-719. PubMed ID: 31653428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine diphosphate-induced single-platelet count aggregation and bleeding in clopidogrel-treated patients undergoing coronary artery bypass grafting.
    Dalén M; van der Linden J; Holm M; Lindvall G; Ivert T
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):230-4. PubMed ID: 24447500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss.
    von Heymann C; Redlich U; Moritz M; Sander M; Vargas Hein O; Grubitzsch H; Konertz WF; Spies C
    Thorac Cardiovasc Surg; 2005 Dec; 53(6):341-5. PubMed ID: 16311970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative platelet inhibition with ASA does not influence postoperative blood loss following coronary artery bypass grafting.
    Gulbins H; Malkoc A; Ennker IC; Ennker J
    Thorac Cardiovasc Surg; 2009 Feb; 57(1):18-21. PubMed ID: 19169991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of aspirin plus heparin with heparin alone on asymptomatic perioperative deep vein thrombosis in candidates for elective off-pump coronary artery bypass graft: a randomized clinical trial.
    Mirhosseini SJ; Forouzannia SK; Mostafavi Pour Manshadi SM; Ali-Hasan-Al-Saegh S; Naderi N; Sanatkar M
    Cardiol J; 2013; 20(2):139-43. PubMed ID: 23558871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin Use Prior to Coronary Artery Bypass Grafting Surgery: a Systematic Review.
    Elbadawi A; Saad M; Nairooz R
    Curr Cardiol Rep; 2017 Feb; 19(2):18. PubMed ID: 28213669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [To what extent does Trasylol decrease the need for blood and blood derivatives in postoperative acetylsalicylic acid (ASA)-induced hemorrhage in CABG surgery?].
    Straus S; Vila H; Kulić M; Donlić E
    Med Arh; 2003; 57(4 Suppl 1):49-51. PubMed ID: 15017865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of preoperative dual antiplatelet therapy on bleeding complications in patients with acute coronary syndromes who undergo urgent coronary artery bypass grafting.
    Nagashima Z; Tsukahara K; Uchida K; Hibi K; Karube N; Ebina T; Imoto K; Kimura K; Umemura S
    J Cardiol; 2017 Jan; 69(1):156-161. PubMed ID: 26987791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
    Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
    Deo SV; Dunlay SM; Shah IK; Altarabsheh SE; Erwin PJ; Boilson BA; Park SJ; Joyce LD
    J Card Surg; 2013 Mar; 28(2):109-16. PubMed ID: 23488578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society.
    Fitchett D; Eikelboom J; Fremes S; Mazer D; Singh S; Bittira B; Brister S; Graham J; Gupta M; Karkouti K; Lee A; Love M; McArthur R; Peterson M; Verma S; Yau T
    Can J Cardiol; 2009 Dec; 25(12):683-9. PubMed ID: 19960127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations.
    Huang J; Donneyong M; Trivedi J; Barnard A; Chaney J; Dotson A; Raymer S; Cheng A; Liu H; Slaughter MS
    Ann Thorac Surg; 2015 Jun; 99(6):1975-81. PubMed ID: 25912742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Preoperative Aspirin Replacement With Enoxaparin in Patients Undergoing Primary Isolated On-Pump Coronary Artery Bypass Grafting.
    Nenna A; Spadaccio C; Prestipino F; Lusini M; Sutherland FW; Beattie GW; Petitti T; Nappi F; Chello M
    Am J Cardiol; 2016 Feb; 117(4):563-570. PubMed ID: 26721653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial.
    Schunkert H; Boening A; von Scheidt M; Lanig C; Gusmini F; de Waha A; Kuna C; Fach A; Grothusen C; Oberhoffer M; Knosalla C; Walther T; Danner BC; Misfeld M; Zeymer U; Wimmer-Greinecker G; Siepe M; Grubitzsch H; Joost A; Schaefer A; Conradi L; Cremer J; Hamm C; Lange R; Radke PW; Schulz R; Laufer G; Grieshaber P; Pader P; Attmann T; Schmoeckel M; Meyer A; Ziegelhöffer T; Hambrecht R; Kastrati A; Sandner SE
    Eur Heart J; 2019 Aug; 40(29):2432-2440. PubMed ID: 31145798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of aspirin on postoperative bleeding in coronary artery bypass grafting.
    Kamran M; Ahmed A; Dar MI; Khan AB
    Ann Thorac Cardiovasc Surg; 2008 Aug; 14(4):224-9. PubMed ID: 18818571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting Bleeding Risk by Platelet Function Testing in Patients Undergoing Heart Surgery.
    Kuliczkowski W; Sliwka J; Kaczmarski J; Zysko D; Zembala M; Steter D; Zembala M; Fortmann S; Serebruany V
    Clin Cardiol; 2015 Nov; 38(11):679-83. PubMed ID: 26447165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting.
    Zhu J; Zhu Y; Zhang M; Xue Q; Hu J; Liu H; Wang R; Wang X; Zhao Q
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):1030-1039.e4. PubMed ID: 32359899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary artery bypass grafting-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelor.
    Hansson EC; Rexius H; Dellborg M; Albertsson P; Jeppsson A
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):699-705; discussion 705. PubMed ID: 24482383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment.
    Tomšič A; Schotborgh MA; Manshanden JS; Li WW; de Mol BA
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):849-856. PubMed ID: 27174551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.